119 related articles for article (PubMed ID: 38467417)
21. Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study.
Yao J; Liu B; Wang X; Yu J; Cheng Z; Han Z; Liu F; Zheng R; Cheng W; Wei Q; Yu S; Li K; Chen P; Luo Y; Yu X; Liang P
Int J Hyperthermia; 2022; 39(1):209-216. PubMed ID: 35067144
[TBL] [Abstract][Full Text] [Related]
22. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
[TBL] [Abstract][Full Text] [Related]
23. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
[TBL] [Abstract][Full Text] [Related]
24. Microwave ablation
Liu W; Zou R; Wang C; Qiu J; Shen J; Liao Y; Yang Z; Zhang Y; Wang Y; Yuan Y; Li K; Zuo D; He W; Zheng Y; Li B; Yuan Y
Ther Adv Med Oncol; 2019; 11():1758835919874652. PubMed ID: 31588210
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: A propensity score matching analysis.
Feng H; Yang C; Xu F; Zhao Y; Jin T; Wei Z; Wang D; Dai C
Eur J Surg Oncol; 2022 Feb; 48(2):418-424. PubMed ID: 34509336
[TBL] [Abstract][Full Text] [Related]
26. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
27. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
28. Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation.
Yang Q; Yu XL; Wang Y; Cheng ZG; Han ZY; Liu FY; Qian TG; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1038-1050. PubMed ID: 33004745
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.
Ma S; Ding M; Li J; Wang T; Qi X; Shi Y; Ming Y; Chi J; Wang Z; Tang X; Cui D; Zhang Y; Zhai B
J Cancer Res Clin Oncol; 2017 Jan; 143(1):131-142. PubMed ID: 27650934
[TBL] [Abstract][Full Text] [Related]
30. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
[No Abstract] [Full Text] [Related]
31. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
[TBL] [Abstract][Full Text] [Related]
32. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
33. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
34. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study.
Han X; Ni JY; Li SL; Deng HX; Liang HM; Xu YY; Huang ZM; Zhang TQ; Huang JH
Abdom Radiol (NY); 2021 Aug; 46(8):3758-3771. PubMed ID: 34032898
[TBL] [Abstract][Full Text] [Related]
36. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
Heerink WJ; Solouki AM; Vliegenthart R; Ruiter SJS; Sieders E; Oudkerk M; de Jong KP
Eur Radiol; 2018 Aug; 28(8):3228-3236. PubMed ID: 29536242
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Role of Albumin-Bilirubin Grade in Hepatocellular Carcinoma After Ultrasound-guided Percutaneous Radiofrequency Ablation: A Single-center Experience Over a Decade.
Long H; Xie X; Huang G; Huang T; Xie X; Liu B
Surg Laparosc Endosc Percutan Tech; 2022 Jun; 32(3):350-356. PubMed ID: 35297807
[TBL] [Abstract][Full Text] [Related]
38. Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.
Yang H; Yang Y; Dou J; Cui R; Cheng Z; Han Z; Liu F; Yu X; Zhou X; Yu J; Liang P
Cancer Biol Med; 2020 May; 17(2):478-491. PubMed ID: 32587783
[No Abstract] [Full Text] [Related]
39. Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.
Chen G; Chen H; Huang X; Cheng S; Zheng S; Wu Y; Zheng T; Chen X; Guo X; Zhang Z; Xie X; Zhang B
Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 36013483
[No Abstract] [Full Text] [Related]
40. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
